Results 161 to 170 of about 6,765 (189)

Hereditary hemorrhagic telangiectasia.

open access: yesHaematologica, 2006
Jamie, McDonald, Pinar, Bayrak-Toydemir
openaire   +1 more source

Hereditary Hemorrhagic Telangiectasia

open access: yesOtolaryngologic Clinics of North America, 2018
Hereditary hemorrhagic telangiectasia (HHT) describes the presenting manifestations of a disorder that is characterized by pathologic blood vessels. HHT is inherited as an autosomal dominant trait with variable penetrance. The abnormal vascular structures (dysplasias) can affect all the organs in the human body. The link between a physical stimulus and
Thomas, Kühnel   +5 more
openaire   +3 more sources

Hereditary hemorrhagic telangiectasia

Oral Surgery, Oral Medicine, Oral Pathology, 1965
Abstract Two cases of hereditary hemorrhagic telangiectasia in Negro patients have been reported. Both cases could be considered classic with respect to the oral lesions and familial history. Although numerous oral lesions and chronic epistaxis were present, severe, persistent anemia was the primary problem to be dealt with in both cases.
R M, SMITH, M, ROBBINS
openaire   +2 more sources

Hereditary Hemorrhagic Telangiectasia

Ophthalmic Plastic & Reconstructive Surgery, 1990
A patient with hereditary hemorrhagic telangiectasia and bloody tears is described. This case report serves to familiarize the ophthalmic plastic and reconstructive surgeon with the differential diagnosis of bloody tears. Conjunctival, oral mucosal and cutaneous findings are documented, and the systemic and ocular manifestations of hereditary ...
S H, Goldberg, J D, Bullock
openaire   +2 more sources

Schizencephaly in Hereditary Hemorrhagic Telangiectasia

American Journal of Neuroradiology, 2022
The presence of malformations of cortical development in patients with hereditary hemorrhagic telangiectasia has been reported on previous occasions. We evaluated a sample of adults with hereditary hemorrhagic telangiectasia for the presence of malformations of cortical development, spatial coincidence of malformations of cortical development and AVMs,
J.J. Gaines   +5 more
openaire   +2 more sources

Hereditary Hemorrhagic Telangiectasia

New England Journal of Medicine, 1995
Identified nearly a century ago, hereditary hemorrhagic telangiectasia, or Rendu–Osler–Weber syndrome, has long been viewed as a rare condition producing minor discomfort for affected persons. However, this disorder is now considered to be more common than previously thought,1–5 and the associated brain and pulmonary lesions are sources of substantial ...
A E, Guttmacher   +2 more
openaire   +2 more sources

Hereditary Hemorrhagic Telangiectasia

Clinics in Chest Medicine, 2016
Hereditary hemorrhagic telangiectasia (HHT) is an underrecognized and underdiagnosed autosomal-dominant angiodysplasia that has an estimated prevalence of 1 in 5000 individuals, with variable clinical presentations even within family members with identical mutations.
openaire   +3 more sources

Hereditary Hemorrhagic Telangiectasia and Gastrointestinal Hemorrhage

Gastroenterology, 1963
Summary In 1.59 patients with hereditary hemorrhagic telangiectasia, the chief manifestation of the disease was hemorrhage (89 per cent), with epistaxis being most common (81 per cent). The telangiectatic lesions were located primarily on the face, mucous membranes of the head, and hands.
C R, SMITH, L G, BARTHOLOMEW, J C, CAIN
openaire   +2 more sources

Hereditary Hemorrhagic Telangiectasia

Archives of Neurology, 1977
To the Editor.— The article entitled "Neurologic Aspects of Hereditary Hemorrhagic Telangiectasia" in the February issue of theArchives(34:101, 1977) prompts me to make the following comment. Approximately two years after the publication of my article 1 on the same subject (quoted in the above article), I had the opportunity to study the mother of ...
openaire   +2 more sources

Hereditary hemorrhagic telangiectasia/avastin

The Laryngoscope, 2009
Abstract This is the first scientific report of hereditary hemorrhagic telangiectasia (HHT) epistaxis treatment by intranasal spraying of the vascular endothelial growth factor (VEGF) inhibitor bevacizumab (Avastin). Epistaxis in patients with HHT is a morbid, mortal condition that is difficult and unpleasant to manage.
Terence M, Davidson   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy